Yarrow Bioscience Inc (YARW) — Cash Flow-to-Debt Ratio
Yarrow Bioscience Inc (YARW) has a Cash Flow-to-Debt Ratio of -3.30x as of March 2026, meaning its operating cash flow of $-4.08 Million could theoretically repay -3% of its total liabilities ($1.24 Million) in one year. Check Yarrow Bioscience Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Yarrow Bioscience Inc Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for Yarrow Bioscience Inc across 11 annual periods. Check Yarrow Bioscience Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Annual Cash Flow-to-Debt Ratio for Yarrow Bioscience Inc (2015–2025)
Year-by-year debt coverage analysis for Yarrow Bioscience Inc. For the full cash flow conversion analysis, see cash flow conversion of Yarrow Bioscience Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -13.83x | $-33.12 Million | $2.40 Million | ▼ -503.3% |
| 2024 | -2.29x | $-33.97 Million | $14.82 Million | ▲ +19.0% |
| 2023 | -2.83x | $-25.34 Million | $8.95 Million | ▲ +7.3% |
| 2022 | -3.06x | $-29.20 Million | $9.56 Million | ▲ +0.2% |
| 2021 | -3.06x | $-56.37 Million | $18.41 Million | ▼ -25.6% |
| 2020 | -2.44x | $-137.08 Million | $56.25 Million | ▲ +60.1% |
| 2019 | -6.11x | $-65.10 Million | $10.66 Million | ▼ -10.6% |
| 2018 | -5.52x | $-52.73 Million | $9.55 Million | ▼ -2321.8% |
| 2017 | -0.23x | $-28.25 Million | $123.90 Million | ▼ -611.4% |
| 2016 | -0.03x | $-2.29 Million | $71.49 Million | ▲ +54.2% |
| 2015 | -0.07x | $-4.18 Million | $59.84 Million | — |